The purpose of this study is to compare the efficacy and safety of Arotinolol Hydrochloride and Metoprolol succinate on morning blood pressure, heart rate and target organ damage in patients with essential hypertension. To provide evidence for hypertension treatment. A group: Arotinolol Hydrochloride, oral, 5-15mg, bid for 12 weeks. B group: Metoprolol succinate sustained-release tablet, oral, 23.75-71.25mg, qd for 12 weeks.
Compare the efficacy and safety of Arotinolol Hydrochloride and Metoprolol succinate on morning blood pressure, heart rate and target organ damage in patients with essential hypertension.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
198
Arotinolol Hydrochloride, oral, 5-15mg, bid for 12 weeks.
Metoprolol succinate sustained-release tablet,oral, 23.75-71.25mg, qd for 12 weeks.
China PLA General Hospital
Beijing, China
Diastolic blood pressure
Changes in diastolic blood pressure measured by ambulatory blood pressure monitoring (ABPM) after treatment
Time frame: 12 weeks
Systolic blood pressure
Changes in systolic blood pressure measured by ABPM after 12 weeks of treatment
Time frame: 12 weeks
Morning surge
Changes in morning surge after 12 weeks of treatment
Time frame: 12 weeks
The increase rate of morning blood pressure
Changes in the increase rate of morning blood pressure after 12 weeks of treatment
Time frame: 12 weeks
Morning blood pressure (BP) by office BP measure
Changes in morning blood pressure by office BP measure after 12 weeks of treatment
Time frame: 12 weeks
Heart rate by office BP measure
Changes in heart rate by office BP measure after 12 weeks of treatment
Time frame: 12 weeks
Pulse wave velocity (PWV)
Changes in PWV after 12 weeks of treatment
Time frame: 12 weeks
Ankle-brachial index (ABI)
Changes in ABI after 12 weeks of treatment
Time frame: 12 weeks
Albumin-to-creatinine ratio (ACR)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Changes in ACR after 12 weeks of treatment
Time frame: 12 weeks
Glomerular filtration rate (GFR)
Changes in GFR after 12 weeks of treatment
Time frame: 12 weeks